ARYx Therapeutics

ARYx Therapeutics, Inc. (OTC Pink: ARYX) is an American biopharmaceutical company, headquartered in Fremont, California, focused on molecular design.

The company uses its RetroMetabolic Drug Design technology to design molecules that retain the efficacy of original and well-established drugs but which are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these original compounds.


    External links

    This article is issued from Wikipedia - version of the 10/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.